Bioinformatic identification and experiment validation revealed that ACTG1 is a promising prognostic signature and therapeutic target for sepsis
Journal of Leukocyte Biology · 2023
DOI: 10.1093/jleuko/qiad072 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Leukocyte Biology, 2023. Verfasst von Hua Yao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, West China Hospital, Sichuan University, No.37 Guoxue Alley, Wuhou District, Chengdu, 610041, Sichuan, China. Hauptthemen laut MEDLINE: Leukocytes, Mononuclear, Sepsis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Sichuan University, China National Key R&D Program of China, China National Key Research and Development Program.
Themen: Sepsis
Abstract (Originalsprache)
In the intensive care unit, sepsis is a prevalent clinical syndrome (i.e. the final pathway to death from most infections). Peripheral blood gene expression profiling is becoming more and more accepted as a potential diagnostic or prognostic tool. This work aimed to recognize genes related to sepsis, providing potential translational therapeutic targets. RNA sequencing was performed on peripheral blood mononuclear cells from 20 healthy control subjects and 51 sepsis patients. Weighted gene coexpression network analysis was employed to pick out sepsis-related and immunocyte-related gene modules. Genes in the yellow module are primarily involved in excessive inflammation and immune suppression. STRING and Cytoscape were combined to identify ACTG1 and IQGAP1 as hub genes with highest connective degree, and prognostic predication value of ACTG1 was confirmed. Both univariate and multivariate logistic regression analyses were carried out. ACTG1 messenger RNA expression was increased in animal and in cell-related sepsis models. Small interfering RNA revealed decreasing ACTG1 can reduce the in vitro sepsis model apoptosis. We have authenticated ACTG1 as a reliable signature of a poor outcome of sepsis and promising therapeutic targets for sepsis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Critical Care Medicine, West China Hospital, Sichuan University, No.37 Guoxue Alley, Wuhou District, Chengdu, 610041, Sichuan, China.
ORCID-Profile: Yan Kang
Förderung
- Sichuan University
- China National Key R&D Program of China
- China National Key Research and Development Program
Zitieren
APA
Yao, H., Zhou, Y., Li, T., Li, Y., Li, F., Zhang, G., Fu, X., Kang, Y., & Wu, Q. (2023). Bioinformatic identification and experiment validation revealed that ACTG1 is a promising prognostic signature and therapeutic target for sepsis. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiad072
Vancouver
Yao H, Zhou Y, Li T, Li Y, Li F, Zhang G, et al. Bioinformatic identification and experiment validation revealed that ACTG1 is a promising prognostic signature and therapeutic target for sepsis. Journal of Leukocyte Biology. 2023. doi:10.1093/jleuko/qiad072
BibTeX
@article{Yao2023,
author = {Yao, Hua and Zhou, Yue and Li, Tingting and Li, Yao and Li, Fan and Zhang, Geng and Fu, Xin and Kang, Yan and Wu, Qin},
title = {Bioinformatic identification and experiment validation revealed that ACTG1 is a promising prognostic signature and therapeutic target for sepsis},
journal = {Journal of Leukocyte Biology},
year = {2023},
doi = {10.1093/jleuko/qiad072}
}
EUVIMED